{"id":4040,"date":"2014-10-08T10:51:56","date_gmt":"2014-10-08T08:51:56","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=4040"},"modified":"2014-10-08T10:51:56","modified_gmt":"2014-10-08T08:51:56","slug":"pr-conclusa-lacquisizione-biofarmitalia","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/pr-conclusa-lacquisizione-biofarmitalia\/","title":{"rendered":"P&amp;R: completed the acquisition of Biofarmitalia"},"content":{"rendered":"<p><i>Il Gruppo P&amp;R \u00e8 una delle prime realt\u00e0 industriali italiane nel settore chimico-farmaceutico, e controlla Fidia Farmaceutici di Abano Terme, Olon Spa di Rodano e Sir Industriale SpA con 1800 dipendenti in totale e un fatturato di circa 500 M <\/i><b><i><\/i><\/b><\/p>\n<p><a href=\"http:\/\/www.etribuna.com\/aas\/it\/chimicafarmaceutica-othermenu-85\/52033-p-r-conclusa-l%E2%80%99acquisizione-di-biofarmitalia-%20.html\" target=\"_blank\" rel=\"noopener\">Pubblicato: 07 Ottobre 2014 \u2013 TRIBUNA ECONOMICA<\/a><\/p>\n<p>P&amp;R Spa ha concluso l\u2019operazione di acquisizione di Biofarmitalia, azienda di Paderno Dugnano forte di un know-how ventennale, leader nella ricerca e produzione di cerotti transcutanei, matrici impregnate e dispositivi medici per la somministrazione di principi attivi per via dermica e orale.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" alt=\"\" src=\"data:image\/jpeg;base64,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\" width=\"240\" height=\"63\" \/>Il Gruppo P&amp;R \u00e8 una delle prime realt\u00e0 industriali italiane nel settore chimico-farmaceutico, e controlla Fidia Farmaceutici di Abano Terme (settore farmaceutico), Olon Spa di Rodano (Principi attivi per l\u2019industria farmaceutica) e Sir Industriale SpA con sede in Macherio (Chimica fine). Il Gruppo, con una consolidata presenza nei mercati esteri attraverso societ\u00e0 e filiali, ha un fatturato di circa 500 M di cui pi\u00f9 del 50 % destinato all\u2019export. Le societ\u00e0 <img loading=\"lazy\" decoding=\"async\" class=\"alignright\" alt=\"\" src=\"https:\/\/encrypted-tbn2.gstatic.com\/images?q=tbn:ANd9GcT5kKp1MmYugt9M3PACqgbKMp2QwxNcI_RWYptvgc1GrHuyCF4BJw\" width=\"166\" height=\"56\" \/>controllate contano 1800 dipendenti.Biofarmitalia \u00e8 stata rilevata da Procedura Fallimentare cui l\u2019azienda era stata recentemente sottoposta a seguito di una profonda crisi finanziaria che tuttavia non ne ha compromesso la capacit\u00e0 operativa, il know how aziendale e l\u2019avviamento commerciale. Nel suddetto periodo di crisi la societ\u00e0 ha continuato ad operare nell\u2019ambito dell\u2019esercizio provvisorio come autorizzato dagli organi competenti.<\/p>\n<p>Con questa acquisizione, Il Gruppo P&amp;R consolida la sua leadership nel settore dei medicinali e dei delivery system innovativi, in termini di quote di mercato ma anche di ricerca e sviluppo.<\/p>","protected":false},"excerpt":{"rendered":"<p>Il Gruppo P&amp;R \u00e8 una delle prime realt\u00e0 industriali italiane nel settore chimico-farmaceutico, e controlla Fidia Farmaceutici di Abano Terme, Olon Spa di Rodano e Sir Industriale SpA con 1800 dipendenti in totale e un fatturato di circa 500 M Pubblicato: 07 Ottobre 2014 \u2013 TRIBUNA ECONOMICA P&amp;R Spa ha concluso l\u2019operazione di acquisizione di &hellip;<\/p>","protected":false},"author":4,"featured_media":4044,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[53],"class_list":["post-4040","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-fusioniacquisizioni"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/4040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=4040"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/4040\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/4044"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=4040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=4040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=4040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}